When hypercalcemia recurred after the fourth chemotherapy cycle, cinacalcet monotherapy induced a consistent decline in PTH-rp levels, thus preventing a further increase in serum calcium levels (11). This evidence concerns the gene PTH and hypercalcemia disease.